Neurobehavioral Medicine Group, Clinical Trials Division — Bloomfield Hills, Michigan

Neurobehavioral Medicine Group, Clinical Trials Division is a clinical research site located in Bloomfield Hills, Michigan, United States 48302.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Neurobehavioral Medicine Group, Clinical Trials Division has participated in 2 clinical trials.

Therapeutic areas: Attention Deficit Hyperactivity Disorder, Schizophrenia.

Sponsors: Sumitomo Pharma America, Inc., Novartis.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neurobehavioral Medicine Group, Clinical Trials Division?

Neurobehavioral Medicine Group, Clinical Trials Division has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neurobehavioral Medicine Group, Clinical Trials Division conducted?

Neurobehavioral Medicine Group, Clinical Trials Division has 2 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder, Schizophrenia.

Is Neurobehavioral Medicine Group, Clinical Trials Division accredited by Crixeo Health?

Neurobehavioral Medicine Group, Clinical Trials Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neurobehavioral Medicine Group, Clinical Trials Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.